Difficulty: Medium
Average Score: 71%
Practice
A 45-year-old man with attention-deficit/hyperactivity disorder presents to his primary care physician for evaluation and treatment. Physical examination of the heart, lungs, and abdomen are within normal limits. The patient has begun on atomoxetine. Which of the following underlying disorders must the treating physician be aware of?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Bipolar disease. When prescribing atomoxetine, the treating physician must be aware of underlying bipolar disorder due to the potential risk of inducing a manic episode with atomoxetine use. Individuals with bipolar disorder may be at an increased risk of mood destabilization when exposed to atomoxetine, which is why monitoring for any signs of mania or hypomania is crucial during treatment.
Option A) Anxiety is incorrect because atomoxetine is actually used in the treatment of ADHD, which often presents with symptoms that can be mistaken for anxiety but are distinct from bipolar disorder.
Option C) Bleeding disorders are not specifically associated with atomoxetine use, so this is an unrelated condition to consider in this context.
Option D) Chronic diarrhea is also unrelated to the use of atomoxetine and would not be a primary concern when initiating treatment for ADHD.
Educationally, this question highlights the importance of considering comorbid conditions and potential interactions when prescribing CNS drugs like atomoxetine. It underscores the need for comprehensive patient assessments and monitoring to ensure safe and effective pharmacological interventions, especially in cases where certain underlying conditions may influence treatment outcomes.
Option A) Anxiety is incorrect because atomoxetine is actually used in the treatment of ADHD, which often presents with symptoms that can be mistaken for anxiety but are distinct from bipolar disorder.
Option C) Bleeding disorders are not specifically associated with atomoxetine use, so this is an unrelated condition to consider in this context.
Option D) Chronic diarrhea is also unrelated to the use of atomoxetine and would not be a primary concern when initiating treatment for ADHD.
Educationally, this question highlights the importance of considering comorbid conditions and potential interactions when prescribing CNS drugs like atomoxetine. It underscores the need for comprehensive patient assessments and monitoring to ensure safe and effective pharmacological interventions, especially in cases where certain underlying conditions may influence treatment outcomes.